U.S. pharma large copyright scrapped two experimental weight loss drugs previous yr—a when-daily capsule, lotiglipron, due to elevated liver enzymes as well as a 2 times-day-to-day pill, danuglipron, as a result of strong Negative effects—but CEO Albert Bourla has reported the company is set to “play and get” during the obesity Place and in